Charles W. Newton Lyell Immunopharma, Inc. (LYEL) insider trading activity

Charles W. Newton is Chief Financial Officer of Lyell Immunopharma, Inc.. Currently has a direct ownership of 15,306 shares of LYEL, which is worth approximately $259,130. The most recent transaction as insider was on Aug 21, 2025, when has been sold 1,453 shares (Common Stock) at a price of $10.54 per share, resulting in proceeds of $15,314. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.3K

0% 3M change

68.59% 12M change

Total Value Held $259,130

Charles W. Newton Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 21 2025	SELL Open market or private sale	$15,314 $10.54 p/Share	1,453 Reduced 8.67%	15,306 Common Stock
Aug 20 2025	BUY Grant, award, or other acquisition	-	8,000 Added 32.31%	16,759 Common Stock
Aug 12 2025	SELL Open market or private sale	$1,406 $10.34 p/Share	136 Reduced 1.53%	8,759 Common Stock
Aug 11 2025	SELL Open market or private sale	$1,379 $10.53 p/Share	131 Reduced 1.45%	8,895 Common Stock
Feb 10 2025	BUY Grant, award, or other acquisition	-	112,500 Added 39.44%	172,725 Common Stock
Feb 09 2024	BUY Grant, award, or other acquisition	-	40,000 Added 45.08%	48,729 Common Stock

Also insider at

CHRS

Coherus BioSciences, Inc. Healthcare

TSVT

2seventy bio, Inc. Healthcare

NVAX

NOVAVAX INC Healthcare

Director

CWN

Charles W. Newton

Chief Financial Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LYEL shares.

Notify only if

Value

Insider Trading

Get notified when an Lyell Immunopharma, Inc. insider buys or sells LYEL shares.

Notify only if

Operation

Value

Type

News

Receive news related to Lyell Immunopharma, Inc.

Track Activities on LYEL

Account